Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
In the Pipe
This is a place to discuss all aspects of drugs in development. Often those in the field are a source of overlooked wisdom in assessing the value of a new drug. If this section becomes popular, it is possible that we may give it its own section on the site. Please feel free to post links to relevant information about new drugs. This board will currently allow anonymous posting, and posts will go live immediately. However, we do ask that you keep discussions on topic. Please understand that we will delete threads/posts that do not provide a useful discussion of new drugs in the pipeline.